SMOC1 and COVID-19: Another limitation and an outstanding research question in the current analysis is it was not designed to assess the contribution of exosomes in the neuropathology caused by COVID-19, which could transfer nucleic acids and cellular debris that could potentially trigger nucleic acid-responsive innate immune mechanisms, such as cGAS-STING and OAS.